Healthcare-focused venture firm W Health Ventures (WHV) has closed its second fund at Rs 700 crore, oversubscribing its initial target of Rs 630 crore.
The fund plans to build 8–10 healthcare companies from the pre-idea stage to category leaders over the next four years.
W Health follows a company-creation model, where its in-house team of physicians, operators and technologists identifies gaps in healthcare delivery and spends 12–18 months evaluating and de-risking an opportunity before bringing in a founding team.
The firm plans to write Rs 30–50 crore cheques and build 2–3 companies every year across India and the US-India corridor.
Fund II has already launched two companies. Everhope Oncology, built with Narayana Health, is focused on coordinated, patient-centric cancer care, while Everbright Health is developing treatments for treatment-resistant depression in the US.
According to W Health Ventures, its portfolio companies have reached 25 million patients to date. The firm said Fund II will focus on solving large, underserved healthcare problems where first-mover solutions can create population-scale impact.
Founded in 2020, W Health Ventures has built companies including Elevate Now, Nivaan, Hoola Health and Everhope Oncology, with offices across Mumbai, Bengaluru, Delhi and Boston.
Disclaimer:
Bareback Media has recently raised funding from a group of investors. Some of the investors may directly or indirectly be involved in a competing business or might be associated with other companies we might write about. This shall, however, not influence our reporting or coverage in any manner whatsoever. You may find a list of our investors here.